{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:08:48Z","timestamp":1795018128390,"version":"4.10.1"},"reference-count":95,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2024,11,25]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>There is a dearth of evidence regarding the global economic burden of ischaemic heart diseases (IHDs). This systematic review aims to synthesise national-level studies worldwide quantifying the economic burden of IHDs from a provider\u2019s perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Embase, Cochrane, DARE and EconLit databases from 1 January 2000 to 29 June 2022. We included observational, cost-of-illness and economic modelling studies reporting direct healthcare cost data for IHDs at the national level. At least two reviewers independently screened titles and abstracts and full texts, extracted data and assessed quality using a seven-question assessment tool. We synthesised findings by country, focusing on three key economic estimates: total annual costs of IHDs, costs of managing acute IHD episodes and chronic IHD care. We correlated these costs with country-specific macroeconomic measures and disease burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 65 national-level studies conducted in 21 countries worldwide, with a majority in high-income countries. The median direct healthcare cost per episode of IHDs was 8062 Int$ 2019 (IQR: 5770\u20139580), and the median direct healthcare cost of IHDs per patient-year was 10\u2009064 Int$ 2019 (IQR: 7619\u201314 818). These estimates positively correlated with country-specific macroeconomic and DALY measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IHDs impose a substantial economic burden on health systems globally. Economic costs in countries exceed per capita public health expenditure, primarily driven by acute episodes. National-level data were available for only 21 countries, and none from low-middle-income and low-income countries. Economic costs of IHDs need to be quantified to inform resource allocation decisions at national and global levels.<\/jats:p>\n                    <jats:p>CRD42022337577.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgh-2024-015043","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T13:11:16Z","timestamp":1739365876000},"page":"e015043","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":30,"title":["The economic burden of ischaemic heart diseases on health systems: a systematic review"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5460-0808","authenticated-orcid":false,"given":"Thanitsara","family":"Rittiphairoj","sequence":"first","affiliation":[{"name":"Health Systems Innovation Lab, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA"},{"name":"Division of Health Systems Management, Department of Community Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"},{"name":"Department of International Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3397-2944","authenticated-orcid":false,"given":"Caroline","family":"Bulstra","sequence":"additional","affiliation":[{"name":"Health Systems Innovation Lab, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA"},{"name":"Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chochat","family":"Ruampatana","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stavridou","sequence":"additional","affiliation":[{"name":"Health Systems Innovation Lab, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Grewal","sequence":"additional","affiliation":[{"name":"Health Systems Innovation Lab, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA"},{"name":"Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che L","family":"Reddy","sequence":"additional","affiliation":[{"name":"Health Systems Innovation Lab, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1531-5983","authenticated-orcid":false,"given":"Rifat","family":"Atun","sequence":"additional","affiliation":[{"name":"Health Systems Innovation Lab, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA"},{"name":"Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA"},{"name":"Department of Global Health and Social Medicine, Harvard Medical School, Harvard University, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"2025072915204409000_10.2.e015043.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.010"},{"key":"2025072915204409000_10.2.e015043.2","unstructured":"World Health Organization . Cardiovascular diseases (CVDs). 2021."},{"key":"2025072915204409000_10.2.e015043.3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30925-9"},{"key":"2025072915204409000_10.2.e015043.4","unstructured":"Bloom DE , Cafiero ET , Jan\u00e9-Llopis E , et al . The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum, 2011."},{"key":"2025072915204409000_10.2.e015043.5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.gheart.2012.08.002","article-title":"Our Time: A Call to Save Preventable Death From Cardiovascular Disease (Heart Disease and Stroke)","volume":"7","author":"Smith Jr.","year":"2012","journal-title":"gh"},{"key":"2025072915204409000_10.2.e015043.6","doi-asserted-by":"crossref","unstructured":"Rifat A , Health Systems Innovation Lab at Harvard University . The State of Cardiovascular Disease in G20+ Countries. HPHR 2022. doi:10.54111\/0001\/HSIL\/cvdg20","DOI":"10.54111\/0001\/HSIL\/cvdg20"},{"key":"2025072915204409000_10.2.e015043.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-018-5806-x","article-title":"The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review","volume":"18","author":"Gheorghe","year":"2018","journal-title":"BMC Public Health"},{"key":"2025072915204409000_10.2.e015043.8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jval.2017.12.019","article-title":"Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review","volume":"21","author":"Einarson","year":"2018","journal-title":"Value Health"},{"key":"2025072915204409000_10.2.e015043.9","doi-asserted-by":"publisher","DOI":"10.1186\/1478-4505-11-31"},{"key":"2025072915204409000_10.2.e015043.10","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025072915204409000_10.2.e015043.11","unstructured":"The World Bank . The world by income and region. 2022. Available: https:\/\/datatopics.worldbank.org\/world-development-indicators\/the-world-by-income-and-region.html [Accessed 10 Jan 2023]."},{"key":"2025072915204409000_10.2.e015043.12","unstructured":"Covidence. Melbourne, Australia: Veritas Health Innovation. Available: www.covidence.org [Accessed 28 Jun 2023]."},{"key":"2025072915204409000_10.2.e015043.13","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-021-02204-0","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"20","author":"Husereau","year":"2022","journal-title":"BMC Med"},{"key":"2025072915204409000_10.2.e015043.14","doi-asserted-by":"publisher","DOI":"10.1332\/174426410X482999"},{"key":"2025072915204409000_10.2.e015043.15","unstructured":"The World Bank . World bank development indicators. Available: https:\/\/data.worldbank.org\/indicator\/ [Accessed 14 Jun 2023]."},{"key":"2025072915204409000_10.2.e015043.16","unstructured":"World Health Organization . Global health expenditure database. Available: https:\/\/apps.who.int\/nha\/database\/Select\/Indicators\/en [Accessed 2 Jun 2023]."},{"key":"2025072915204409000_10.2.e015043.17","unstructured":"Institute for Health Metrics and Evaluation . GBD compare. Seattle, WA:IHME, University of Washington; 2015. Available: http:\/\/vizhub.healthdata.org\/gbd-compare"},{"key":"2025072915204409000_10.2.e015043.18","unstructured":"RStudio Team . RStudio: integrated development for r. In: RStudio, PBC. Boston, MA, 2020. Available: http:\/\/www.rstudio.com"},{"key":"2025072915204409000_10.2.e015043.19","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/864962","article-title":"The Economic Burden of HIV\/AIDS and myocardial infarction treatment in Brazil","volume":"2013","author":"Ara\u00fajo","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"2025072915204409000_10.2.e015043.20","first-page":"S149","article-title":"Coronary artery disease in the Thai population: data from health situation analysis 2010","volume":"95 Suppl 7","author":"Kiatchoosakun","year":"2012","journal-title":"J Med Assoc Thai"},{"key":"2025072915204409000_10.2.e015043.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2004.00219.x"},{"key":"2025072915204409000_10.2.e015043.22","doi-asserted-by":"crossref","unstructured":"Chapman RH , Liu LZ , Girase PG , et al . Determining initial and follow-up costs of cardiovascular events in a US managed care population. BMC Cardiovasc Disord 2011;11. doi:10.1186\/1471-2261-11-11","DOI":"10.1186\/1471-2261-11-11"},{"key":"2025072915204409000_10.2.e015043.23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/CEOR.S43672","article-title":"Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population","volume":"5","author":"Chen","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"key":"2025072915204409000_10.2.e015043.24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3519","article-title":"Variation in and Hospital Characteristics Associated With the Value of Care for Medicare Beneficiaries With Acute Myocardial Infarction, Heart Failure, and Pneumonia","volume":"1","author":"Desai","year":"2018","journal-title":"JAMA Netw Open"},{"key":"2025072915204409000_10.2.e015043.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.0734"},{"key":"2025072915204409000_10.2.e015043.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.10.048"},{"key":"2025072915204409000_10.2.e015043.27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000590","article-title":"Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States","volume":"3","author":"Kolte","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2025072915204409000_10.2.e015043.28","first-page":"80","article-title":"Cost of coronary syndrome treated with percutaneous coronary intervention and 30-day unplanned readmission in the United States","volume":"97","author":"Kwok","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025072915204409000_10.2.e015043.29","first-page":"665","article-title":"Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost","volume":"11","author":"Kwok","year":"2018","journal-title":"JACC: Cardiovascular Interventions"},{"key":"2025072915204409000_10.2.e015043.30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001057","article-title":"Outcomes and resource utilization in ST-elevation myocardial infarction in the United States: evidence for socioeconomic disparities","volume":"3","author":"Agarwal","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2025072915204409000_10.2.e015043.31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.114.000927"},{"key":"2025072915204409000_10.2.e015043.32","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903479331"},{"key":"2025072915204409000_10.2.e015043.33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011322","article-title":"Acute and 1-Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE-ACS Registry","volume":"8","author":"Cowper","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025072915204409000_10.2.e015043.34","first-page":"403","article-title":"Costs associated with cardiovascular events in patients with hypertension in US managed care settings","volume":"3","author":"Duh","year":"2009","journal-title":"Journal of the American"},{"key":"2025072915204409000_10.2.e015043.35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015503","article-title":"Associations Between Hospital Length of Stay, 30-Day Readmission, and Costs in ST-Segment-Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: A Nationwide Readmissions Database Analysis","volume":"9","author":"Jang","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025072915204409000_10.2.e015043.36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/VHRM.S146266","article-title":"Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease","volume":"14","author":"Power","year":"2018","journal-title":"Vasc Health Risk Manag"},{"key":"2025072915204409000_10.2.e015043.37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/pop.2011.0008","article-title":"Quality of care, health care costs, and utilization among Medicare Part D enrollees with and without low-income subsidy","volume":"15","author":"Priest","year":"2012","journal-title":"Popul Health Manag"},{"key":"2025072915204409000_10.2.e015043.38","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000141417.66620.09"},{"key":"2025072915204409000_10.2.e015043.39","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2015.1659"},{"key":"2025072915204409000_10.2.e015043.40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.781138"},{"key":"2025072915204409000_10.2.e015043.41","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ahj.2015.09.009","article-title":"Trends in acute myocardial infarction hospitalizations: Are we seeing the whole picture?","volume":"170","author":"Sacks","year":"2015","journal-title":"Am Heart J"},{"key":"2025072915204409000_10.2.e015043.42","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004996","article-title":"Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel Survey","volume":"6","author":"Salami","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2025072915204409000_10.2.e015043.43","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007132","article-title":"National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel Survey","volume":"7","author":"Salami","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2025072915204409000_10.2.e015043.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2004.11.006"},{"key":"2025072915204409000_10.2.e015043.45","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2007.0596"},{"key":"2025072915204409000_10.2.e015043.46","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2840-8-53","article-title":"Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting","volume":"8","author":"Straka","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"2025072915204409000_10.2.e015043.47","article-title":"Time trends of clinical outcome and spending of care for acute myocardial infarction hospitalizations in the United States, 2001-2011","volume":"29","author":"Sugiyama","year":"2014","journal-title":"J Gen Intern Med"},{"key":"2025072915204409000_10.2.e015043.48","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2009.241"},{"key":"2025072915204409000_10.2.e015043.49","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/1755-5922.12222","article-title":"Clinical and economic outcomes among elderly myocardial infarction survivors in the United States","volume":"34","author":"Yang","year":"2016","journal-title":"Cardiovasc Ther"},{"key":"2025072915204409000_10.2.e015043.50","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1016\/j.amepre.2017.07.012","article-title":"Medical Expenditures Associated With Diabetes in Myocardial Infarction and Ischemic Stroke Patients","volume":"53","author":"Zhou","year":"2017","journal-title":"Am J Prev Med"},{"key":"2025072915204409000_10.2.e015043.51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ehjqcco\/qcw003","article-title":"Long-term healthcare use and costs in patients with stable coronary artery disease: a population-based cohort using linked health records (CALIBER)","volume":"2","author":"Walker","year":"2016","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025072915204409000_10.2.e015043.52","doi-asserted-by":"crossref","unstructured":"Beswick A , Rees K , Griebsch I , et al . Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups. Health Technol Assess 2004;8. doi:10.3310\/hta8410","DOI":"10.3310\/hta8410"},{"key":"2025072915204409000_10.2.e015043.53","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011805","article-title":"Estimating the economic burden of cardiovascular events in patients receiving lipid-modifying therapy in the UK","volume":"6","author":"Danese","year":"2016","journal-title":"BMJ Open"},{"key":"2025072915204409000_10.2.e015043.54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1504\/IJHTM.2009.025820","article-title":"Treatments, outcomes, and costs for AMI patients in Taiwan","volume":"10","author":"Yip","year":"2009","journal-title":"IJHTM"},{"key":"2025072915204409000_10.2.e015043.55","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-007-6044-0"},{"key":"2025072915204409000_10.2.e015043.56","article-title":"Cost of acute coronary syndrome in Switzerland in 2008","volume":"142","author":"Wieser","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"2025072915204409000_10.2.e015043.57","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2261-13-55","article-title":"Economic burden of acute coronary syndrome in South Korea: a national survey","volume":"13","author":"Kim","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"2025072915204409000_10.2.e015043.58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117446","article-title":"Recent trends in economic burden of acute myocardial infarction in South Korea","volume":"10","author":"Seo","year":"2015","journal-title":"PLoS One"},{"key":"2025072915204409000_10.2.e015043.59","first-page":"105","article-title":"Simulation analysis of economic burden in hypertension and myocardial infarction treatment with beta blockers","volume":"81","author":"Atanasijevi\u0107-Kunc","year":"2012","journal-title":"Zdravniski Vestnik"},{"key":"2025072915204409000_10.2.e015043.60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002716","article-title":"Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand","volume":"16","author":"Blakely","year":"2019","journal-title":"PLoS Med"},{"key":"2025072915204409000_10.2.e015043.61","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017775","article-title":"Characteristics and healthcare utilisation patterns of high-cost beneficiaries in the Netherlands: a cross-sectional claims database study","volume":"7","author":"Wammes","year":"2017","journal-title":"BMJ Open"},{"key":"2025072915204409000_10.2.e015043.62","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12471-013-0386-y","article-title":"Treatment costs of acute myocardial infarction in the Netherlands","volume":"21","author":"Soekhlal","year":"2013","journal-title":"Neth Heart J"},{"key":"2025072915204409000_10.2.e015043.63","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.5551\/jat.28852","article-title":"High-Risk Atherosclerotic Cardiovascular Disease in a Real-World Employed Japanese Population: Prevalence, Cardiovascular Event Rates, and Costs","volume":"22","author":"Davis","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"2025072915204409000_10.2.e015043.64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10198-021-01358-1","article-title":"The economic burden of obesity in Italy: a cost-of-illness study","volume":"23","author":"d\u2019Errico","year":"2022","journal-title":"Eur J Health Econ"},{"key":"2025072915204409000_10.2.e015043.65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03337744","article-title":"The occurrence of acute myocardial infarction in Italy: a five-year analysis of hospital discharge records","volume":"23","author":"Piscitelli","year":"2011","journal-title":"Aging Clin Exp Res"},{"key":"2025072915204409000_10.2.e015043.66","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-2137"},{"key":"2025072915204409000_10.2.e015043.67","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s10389-005-0112-3","article-title":"Cost of atherothrombotic diseases\u2014myocardial infarction, ischaemic stroke and peripheral arterial occlusive disease\u2014in Germany","volume":"13","author":"Br\u00fcggenj\u00fcrgen","year":"2005","journal-title":"J Public Health"},{"key":"2025072915204409000_10.2.e015043.68","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.healthpol.2015.01.012","article-title":"The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention","volume":"119","author":"Becker","year":"2015","journal-title":"Health Policy"},{"key":"2025072915204409000_10.2.e015043.69","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu043"},{"key":"2025072915204409000_10.2.e015043.70","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.diabet.2006.12.004","article-title":"Costs of cardiovascular events of diabetic patients in the French hospitals","volume":"33","author":"Colin","year":"2007","journal-title":"Diabetes Metab"},{"key":"2025072915204409000_10.2.e015043.71","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/13696998.2020.1715415","article-title":"Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis","volume":"23","author":"Emery","year":"2020","journal-title":"J Med Econ"},{"key":"2025072915204409000_10.2.e015043.72","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2261-12-25","article-title":"The aging Canadian population and hospitalizations for acute myocardial infarction: projection to 2020","volume":"12","author":"Rawson","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"2025072915204409000_10.2.e015043.73","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl161"},{"key":"2025072915204409000_10.2.e015043.74","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10557-008-6128-5","article-title":"Atherosclerotic cardiovascular diseases in Belgium: a cost-of-illness analysis","volume":"22","author":"Vlayen","year":"2008","journal-title":"Cardiovasc Drugs Ther"},{"key":"2025072915204409000_10.2.e015043.75","first-page":"63","article-title":"Current and future costs of cancer, heart disease and stroke attributable to obesity in Australia - a comparison of two birth cohorts","volume":"18","author":"Aitken","year":"2009","journal-title":"Asia Pac J Clin Nutr"},{"key":"2025072915204409000_10.2.e015043.76","first-page":"235","article-title":"Modelling the Burden of Cardiovascular Disease in Turkey: Part 1","volume":"20","author":"Balbay","year":"2018","journal-title":"Anatol J Cardiol"},{"key":"2025072915204409000_10.2.e015043.77","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jphs.12298","article-title":"Cost analysis of management of cardiovascular disease comorbidities in Turkey","volume":"10","author":"Ko\u00e7kaya","year":"2019","journal-title":"J Pharm Health Serv Res"},{"key":"2025072915204409000_10.2.e015043.78","first-page":"2867","article-title":"Economic Burden of Smoking in Iran: A Prevalence-Based Annual Cost Approach","volume":"18","author":"Rezaei","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"2025072915204409000_10.2.e015043.79","doi-asserted-by":"crossref","first-page":"649624","DOI":"10.3389\/fpubh.2021.649624","article-title":"Economic Burden of Major Diseases in China in 2013","volume":"9","author":"Song","year":"2021","journal-title":"Front Public Health"},{"key":"2025072915204409000_10.2.e015043.80","first-page":"303","article-title":"Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system","volume":"62","author":"Bahia","year":"2018","journal-title":"Arch Endocrinol Metab"},{"key":"2025072915204409000_10.2.e015043.81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210502","article-title":"The distribution of cardiac diagnostic testing for acute coronary syndrome in the Brazilian healthcare system: A national geospatial evaluation of health access","volume":"14","author":"Hertz","year":"2019","journal-title":"PLoS One"},{"key":"2025072915204409000_10.2.e015043.82","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15020294","article-title":"Disease and Economic Burden of Hospitalizations Attributable to Diabetes Mellitus and Its Complications: A Nationwide Study in Brazil","volume":"15","author":"Rosa","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"2025072915204409000_10.2.e015043.83","first-page":"29","article-title":"The Economic Burden of Heart Conditions in Brazil","volume":"111","author":"Stevens","year":"2018","journal-title":"Arq Bras Cardiol"},{"key":"2025072915204409000_10.2.e015043.84","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-17-00319"},{"key":"2025072915204409000_10.2.e015043.85","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-021-06648-1","article-title":"Strengthening routine health information systems for analysis and data use: a tipping point","volume":"21","author":"Amouzou","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"2025072915204409000_10.2.e015043.86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239683","article-title":"Improving quality and use of routine health information system data in low- and middle-income countries: A scoping review","volume":"15","author":"Lemma","year":"2020","journal-title":"PLoS One"},{"key":"2025072915204409000_10.2.e015043.87","doi-asserted-by":"crossref","unstructured":"Kim S-H , Ro J , Kim Y , et al . Underutilization of Hospital-based Cardiac Rehabilitation after Acute Myocardial Infarction in Korea. J Korean Med Sci 2020;35. doi:10.3346\/jkms.2020.35.e262","DOI":"10.3346\/jkms.2020.35.e262"},{"key":"2025072915204409000_10.2.e015043.88","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/clc.23911","article-title":"Cardiac rehabilitation: Effective yet underutilized in patients with cardiovascular disease","volume":"45","author":"Bracewell","year":"2022","journal-title":"Clin Cardiol"},{"key":"2025072915204409000_10.2.e015043.89","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/2047487319827453","article-title":"Cardiac rehabilitation availability and delivery in Europe: How does it differ by region and compare with other high-income countries?: Endorsed by the European Association of Preventive Cardiology","volume":"26","author":"Abreu","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2025072915204409000_10.2.e015043.90","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jacc.2023.01.019","article-title":"Cardiac Rehabilitation Underutilization: The Need for Innovative Delivery","volume":"81","author":"Brown","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2025072915204409000_10.2.e015043.91","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.socscimed.2005.07.001","article-title":"What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts?","volume":"62","author":"McIntyre","year":"2006","journal-title":"Social Science & Medicine"},{"key":"2025072915204409000_10.2.e015043.92","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare11070959","article-title":"A Systematic Literature Review of Health Information Systems for Healthcare","volume":"11","author":"Epizitone","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"2025072915204409000_10.2.e015043.93","unstructured":"Evaluation M . Strengthening Health Information Systems in Low- and Middle-Income Countries: A Model to Frame What We Know and What We Need to Learn. Chapel Hill, NC, USA: MEASURE Evaluation, 2019."},{"key":"2025072915204409000_10.2.e015043.94","unstructured":"Evaluation M . What are the characteristics of a strong health information system. 2018. Available: https:\/\/www.measureevaluation.org\/resources\/publications\/fs-18-294\/at_download\/document"},{"key":"2025072915204409000_10.2.e015043.95","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2223-3652.2012.01.02"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2024-015043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T22:21:01Z","timestamp":1753827661000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2024-015043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":95,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,12]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjgh-2024-015043"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2024-015043","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}